Vulval cancer: prevention and screening
| Autor: | Allan B. Maclean |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
medicine.medical_specialty
animal structures Lichen sclerosus Vulvar Lichen Sclerosus Vulva Patient Education as Topic Terminology as Topic medicine Humans Mass Screening Pathological Gynecology Intraepithelial neoplasia Vulvar Neoplasms urogenital system business.industry Incidence (epidemiology) fungi Lichen Planus Obstetrics and Gynecology Vulval cancer General Medicine medicine.disease Dermatology female genital diseases and pregnancy complications medicine.anatomical_structure embryonic structures Disease Progression Etiology Female business Vulval intraepithelial neoplasia Precancerous Conditions Carcinoma in Situ |
| Zdroj: | Best Practice & Research Clinical Obstetrics & Gynaecology. 20:379-395 |
| ISSN: | 1521-6934 |
| DOI: | 10.1016/j.bpobgyn.2005.11.001 |
| Popis: | The incidence of vulval cancer is rising, both in older women and those under 50 years of age. Vulval cancer has at least two types, one arising in association with lichen sclerosus (LS) and the other with vulval intraepithelial neoplasia (VIN). Recent pathological and aetiological descriptions are included, along with the latest description of VIN terminology. Prevention of and screening for vulval cancer will require greater understanding of why some women with LS and VIN are at greater risk: recent studies of molecular change might contribute to this. The use of vulval cytology and toluidine blue staining is described. Patient or vulval awareness may help but clinical features are non-specific. Prophylactic vaccination against HPV and campaigns against smoking may contribute in the future. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect